Method of safe administration of phosphorylated tau peptide vaccine
US11684576B2 · kind B2 · utility
1Cited by
6References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 7, 2020 |
| Grant date | Jun 27, 2023 |
| Priority date | — |
| Expiry date | Nov 18, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/627
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for inducing anti-phosphorylated Tau antibodies without inducing a severe adverse event in humans are described. The methods include administering to the subject an effective amount of liposomes including a toll-like receptor 4 agonist and a Tau phosphopeptide presented on the surface of the liposome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.